Israel Englander’s Kindred Biosciences, Inc. KIN Stock Holding History

Israel Englander’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,000	Closed	-$205K	–	4805
2019 Q3	$205K	Sell	30,000 -86,900	-74%	-$637K	﹤0.01%	3779
2019 Q2	$974K	Buy	+116,900	New	+$1.01M	﹤0.01%	2830

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

Israel Englander's KIN Position: Q3 2021 in Review

Israel Englander sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 2,751,857 shares — an estimated $25.2M sold.

Israel Englander first reported a position in KIN in Q3 2014 and held it in 20 quarters. The position peaked at $25.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Israel Englander reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Israel Englander sold 2,751,857 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $25.2M.
Israel Englander first reported a position in Kindred Biosciences, Inc. in Q3 2014 and held it in 20 quarters.
Israel Englander's Kindred Biosciences, Inc. position peaked at $25.2M in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.